{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T23:09:21Z","timestamp":1765667361658},"reference-count":23,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2021,11,18]],"date-time":"2021-11-18T00:00:00Z","timestamp":1637193600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,5,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Evaluating the usefulness of intestinal anti-transglutaminase IgA (anti-TG2 IgA) deposits detection as a complementary or decision-supporting tool in the diagnosis of celiac disease (CD) in patients with low degree of enteropathy. Small intestinal biopsies (SIB) were performed from 2008 to 2017 in patients on suspicion of CD (positive CD serology and\/or symptoms) referred to our Pediatric Gastroenterology Unit. We determined anti-TG2 IgA deposits by using double immunofluorescence in all the patients in whom Marsh 0 or Marsh 1 was detected in the conventional histological study and in a random selection of patients with clearly positive serology and histological Marsh 2\u20133 lesion. Seventy-five pediatric patients were split into three groups according to the final diagnosis: (i) 13 children with a Marsh 0 or 1, negative CD serology and final non-CD diagnosis; none presented intestinal anti-TG2 IgA deposits; (ii) 15 potential CD cases (Marsh 0 or 1 and CD-associated antibodies), detecting anti-TG2 IgA deposits in 12; on follow-up, another biopsy performed in 11\/15 showed villi atrophy in seven and a Marsh 2 lesion in two of them, patients being finally diagnosed as CD cases; and (iii) 47 children with Marsh 2\u20133 histological lesion and final CD diagnosis; all of them had intestinal anti-TG2 IgA deposits. Anti-TG2 deposits are a useful complementary tool for CD diagnosis in pediatric population with digestive pathologies suggestive of CD. It is especially helpful in those with low-grade lesion, in which anti-TG2 deposits are predictive of the development of more severe lesions on follow-up.<\/jats:p>","DOI":"10.1093\/cei\/uxab010","type":"journal-article","created":{"date-parts":[[2022,1,12]],"date-time":"2022-01-12T18:52:03Z","timestamp":1642013523000},"page":"279-286","source":"Crossref","is-referenced-by-count":4,"title":["Intestinal anti-tissue transglutaminase IgA deposits as a complementary method for the diagnostic evaluation of celiac disease in patients with low-grade histological lesions"],"prefix":"10.1093","volume":"207","author":[{"given":"Mar\u00eda","family":"Roca","sequence":"first","affiliation":[{"name":"Celiac Disease and Digestive Immunopathology Unit, Instituto de Investigaci\u00f3n Sanitaria La Fe, Valencia, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ester","family":"Donat","sequence":"additional","affiliation":[{"name":"Celiac Disease and Digestive Immunopathology Unit, Instituto de Investigaci\u00f3n Sanitaria La Fe, Valencia, Spain"},{"name":"Pediatric Gastrohepathology Unit, Hospital Universitario y Polit\u00e9cnico La Fe, Valencia, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Etna","family":"Masip","sequence":"additional","affiliation":[{"name":"Celiac Disease and Digestive Immunopathology Unit, Instituto de Investigaci\u00f3n Sanitaria La Fe, Valencia, Spain"},{"name":"Pediatric Gastrohepathology Unit, Hospital Universitario y Polit\u00e9cnico La Fe, Valencia, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ver\u00f3nica","family":"Ballester","sequence":"additional","affiliation":[{"name":"Celiac Disease and Digestive Immunopathology Unit, Instituto de Investigaci\u00f3n Sanitaria La Fe, Valencia, Spain"},{"name":"Pediatric Gastrohepathology Unit, Hospital Universitario y Polit\u00e9cnico La Fe, Valencia, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabel","family":"G\u00f3mez","sequence":"additional","affiliation":[{"name":"Celiac Disease and Digestive Immunopathology Unit, Instituto de Investigaci\u00f3n Sanitaria La Fe, Valencia, Spain"},{"name":"Pediatric Gastrohepathology Unit, Hospital Universitario y Polit\u00e9cnico La Fe, Valencia, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mercedes","family":"SanFelix","sequence":"additional","affiliation":[{"name":"Celiac Disease and Digestive Immunopathology Unit, Instituto de Investigaci\u00f3n Sanitaria La Fe, Valencia, Spain"},{"name":"Pediatric Gastrohepathology Unit, Hospital Universitario y Polit\u00e9cnico La Fe, Valencia, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Ramos","sequence":"additional","affiliation":[{"name":"Celiac Disease and Digestive Immunopathology Unit, Instituto de Investigaci\u00f3n Sanitaria La Fe, Valencia, Spain"},{"name":"Pathology Unit, Hospital Universitario y Polit\u00e9cnico La Fe, Valencia, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joaquim","family":"Calvo-Lerma","sequence":"additional","affiliation":[{"name":"Celiac Disease and Digestive Immunopathology Unit, Instituto de Investigaci\u00f3n Sanitaria La Fe, Valencia, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lola","family":"Giner-P\u00e9rez","sequence":"additional","affiliation":[{"name":"Celiac Disease and Digestive Immunopathology Unit, Instituto de Investigaci\u00f3n Sanitaria La Fe, Valencia, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miguel","family":"Bolonio","sequence":"additional","affiliation":[{"name":"Celiac Disease and Digestive Immunopathology Unit, Instituto de Investigaci\u00f3n Sanitaria La Fe, Valencia, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bego\u00f1a","family":"Polo","sequence":"additional","affiliation":[{"name":"Celiac Disease and Digestive Immunopathology Unit, Instituto de Investigaci\u00f3n Sanitaria La Fe, Valencia, Spain"},{"name":"Pediatric Gastrohepathology Unit, Hospital Universitario y Polit\u00e9cnico La Fe, Valencia, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carmen","family":"Ribes-Koninckx","sequence":"additional","affiliation":[{"name":"Celiac Disease and Digestive Immunopathology Unit, Instituto de Investigaci\u00f3n Sanitaria La Fe, Valencia, Spain"},{"name":"Pediatric Gastrohepathology Unit, Hospital Universitario y Polit\u00e9cnico La Fe, Valencia, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2021,11,18]]},"reference":[{"key":"2022051714125056500_CIT0001","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1097\/MPG.0b013e31821a23d0","article-title":"European Society for Pediatric Gastroenterology, Hepatology, and Nutrition guidelines for the diagnosis of coeliac disease.","volume":"54","author":"Husby","year":"2012","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"2022051714125056500_CIT0002","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1097\/MPG.0000000000002497","article-title":"European Society Paediatric Gastroenterology, Hepatology and Nutrition guidelines for diagnosing coeliac disease 2020.","volume":"70","author":"Husby","year":"2020","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"2022051714125056500_CIT0003","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1053\/j.gastro.2020.04.018","article-title":"Evidence that pathogenic transglutaminase 2 in celiac disease derives from enterocytes.","volume":"159","author":"Iversen","year":"2020","journal-title":"Gastroenterology"},{"key":"2022051714125056500_CIT0004","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1136\/gut.2003.024836","article-title":"In vivo targeting of intestinal and extraintestinal transglutaminase 2 by coeliac autoantibodies.","volume":"53","author":"Korponay-Szab\u00f3","year":"2004","journal-title":"Gut"},{"key":"2022051714125056500_CIT0005","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/j.1572-0241.2002.05426.x","article-title":"Antiendomysial antibody detection in fecal supernatants: in vivo proof that small bowel mucosa is the site of antiendomysial antibody production.","volume":"97","author":"Picarelli","year":"2002","journal-title":"Am J Gastroenterol"},{"key":"2022051714125056500_CIT0006","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/S0140-6736(96)03060-7","article-title":"Production of antiendomysial antibodies after in-vitro gliadin challenge of small intestine biopsy samples from patients with coeliac disease.","volume":"348","author":"Picarelli","year":"1996","journal-title":"Lancet"},{"key":"2022051714125056500_CIT0007","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/j.1365-2249.2012.04673.x","article-title":"Intestinal anti-tissue transglutaminase antibodies in potential coeliac disease.","volume":"171","author":"Tosco","year":"2013","journal-title":"Clin Exp Immunol"},{"key":"2022051714125056500_CIT0008","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.cgh.2010.09.006","article-title":"Natural history of potential celiac disease in children.","volume":"9","author":"Tosco","year":"2011","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2022051714125056500_CIT0009","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1136\/adc.65.8.909","article-title":"Revised criteria for the diagnosis of celiac disease. Report of Working Group of European Society of Paediatric Gastroenterology and Nutrition.","volume":"65","author":"Walker","year":"1990","journal-title":"Arch Dis Child"},{"key":"2022051714125056500_CIT0010","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1097\/00042737-199910000-00019","article-title":"The histopathology of coeliac disease: time for a standardized report scheme for pathologists.","volume":"11","author":"Oberhuber","year":"1999","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"2022051714125056500_CIT0011","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1111\/j.1365-2036.2006.02997.x","article-title":"Immunoglobulin A autoantibodies against transglutaminase 2 in the small intestinal mucosa predict forthcoming coeliac disease.","volume":"24","author":"Salmi","year":"2006","journal-title":"Aliment Pharmacol Ther"},{"key":"2022051714125056500_CIT0012","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1111\/cei.13078","article-title":"Intestinal anti-transglutaminase 2 immunoglobulin A deposits in children at risk for coeliac disease (CD): data from the PreventCD study.","volume":"191","author":"Borrelli","year":"2018","journal-title":"Clin Exp Immunol"},{"key":"2022051714125056500_CIT0013","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1097\/MCG.0b013e3181b64557","article-title":"Usefulness of small-bowel mucosal transglutaminase-2 specific autoantibody deposits in the diagnosis and follow-up of celiac disease.","volume":"44","author":"Koskinen","year":"2010","journal-title":"J Clin Gastroenterol"},{"key":"2022051714125056500_CIT0014","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.dld.2009.04.004","article-title":"Diagnostic methods beyond conventional histology in coeliac disease diagnosis.","volume":"42","author":"Salmi","year":"2010","journal-title":"Dig Liver Dis"},{"key":"2022051714125056500_CIT0015","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.dld.2011.01.015","article-title":"Intestinal deposits of anti-tissue transglutaminase IgA in childhood celiac disease.","volume":"43","author":"Maglio","year":"2011","journal-title":"Dig Liver Dis"},{"key":"2022051714125056500_CIT0016","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1097\/MPG.0b013e3181b99c8f","article-title":"Serum and intestinal celiac disease-associated antibodies in children with celiac disease younger than 2 years of age.","volume":"50","author":"Maglio","year":"2010","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"2022051714125056500_CIT0017","first-page":"9","article-title":"Beyond the intestinal celiac mucosa: diagnostic role of anti-TG2 deposits, a systematic review.","volume":"1","author":"Gatti","year":"2014","journal-title":"Front Med (Lausanne)"},{"key":"2022051714125056500_CIT0018","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1097\/MPG.0b013e3181677067","article-title":"Immunoglobulin A anti-tissue transglutaminase antibody deposits in the small intestinal mucosa of children with no villous atrophy.","volume":"47","author":"Tosco","year":"2008","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"2022051714125056500_CIT0019","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1080\/00365520510023422","article-title":"Small-bowel mucosal transglutaminase 2-specific IgA deposits in coeliac disease without villous atrophy: a prospective and randomized clinical study.","volume":"40","author":"Kaukinen","year":"2005","journal-title":"Scand J Gastroenterol"},{"key":"2022051714125056500_CIT0020","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.3390\/nu9101050","article-title":"Intestinal production of anti-tissue transglutaminase 2 antibodies in patients with diagnosis other than celiac disease.","volume":"9","author":"Maglio","year":"2017","journal-title":"Nutrients"},{"key":"2022051714125056500_CIT0021","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.jpeds.2010.02.070","article-title":"Celiac disease without villous atrophy in children: a prospective study.","volume":"157","author":"Kurppa","year":"2010","journal-title":"J Pediatr"},{"key":"2022051714125056500_CIT0022","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.2337\/db08-0962","article-title":"Majority of children with type 1 diabetes produce and deposit anti-tissue transglutaminase antibodies in the small intestine.","volume":"58","author":"Maglio","year":"2009","journal-title":"Diabetes"},{"key":"2022051714125056500_CIT0023","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1097\/MPG.0000000000002917","article-title":"Seronegative villous atrophy in children: clinical and immunohistochemical features.","volume":"72","author":"Mandile","year":"2021","journal-title":"J Pediatr Gastroenterol Nutr"}],"container-title":["Clinical and Experimental Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/cei\/advance-article-pdf\/doi\/10.1093\/cei\/uxab010\/42547302\/uxab010.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/207\/3\/279\/43692269\/uxab010.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/207\/3\/279\/43692269\/uxab010.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,17]],"date-time":"2022-05-17T16:31:34Z","timestamp":1652805094000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cei\/article\/207\/3\/279\/6431352"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,18]]},"references-count":23,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2021,11,18]]},"published-print":{"date-parts":[[2022,5,12]]}},"URL":"https:\/\/doi.org\/10.1093\/cei\/uxab010","relation":{},"ISSN":["0009-9104","1365-2249"],"issn-type":[{"value":"0009-9104","type":"print"},{"value":"1365-2249","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,3,1]]},"published":{"date-parts":[[2021,11,18]]}}}